Bank of Nova Scotia’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Buy |
+594,812
| New | +$10.3M | 0.02% | 382 |
|
|
2024
Q1 | – | Sell |
-6,443
| Closed | -$386K | – | 962 |
|
|
2023
Q4 | $386K | Sell |
6,443
-286,862
| -98% | -$17.2M | ﹤0.01% | 891 |
|
|
2023
Q3 | $11.2M | Buy |
293,305
+288,685
| +6,249% | +$11M | 0.03% | 303 |
|
|
2023
Q2 | $421K | Buy |
+4,620
| New | +$421K | ﹤0.01% | 855 |
|